Cargando…
Periostin is a novel histological biomarker for the diagnosis of chondroid tumor
BACKGROUND: The chondroid tumor is generally classified into three types, enchondroma, low-grade chondrosarcoma, and high-grade chondrosarcoma. A histological evaluation of a biopsy sample is the best predictor of the clinical course in most patients with carcinomas or sarcomas. Sometimes serologica...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798228/ https://www.ncbi.nlm.nih.gov/pubmed/35116273 http://dx.doi.org/10.21037/tcr-20-2499 |
_version_ | 1784641749796257792 |
---|---|
author | Kim, Dough Jeong, Ji Yun Han, Man-Hoon Chae, Jongmin Park, Ilhyung Yoon, Jongphil Kyung, Heesoo Kim, Ha-Jeong Jeong, Wonju |
author_facet | Kim, Dough Jeong, Ji Yun Han, Man-Hoon Chae, Jongmin Park, Ilhyung Yoon, Jongphil Kyung, Heesoo Kim, Ha-Jeong Jeong, Wonju |
author_sort | Kim, Dough |
collection | PubMed |
description | BACKGROUND: The chondroid tumor is generally classified into three types, enchondroma, low-grade chondrosarcoma, and high-grade chondrosarcoma. A histological evaluation of a biopsy sample is the best predictor of the clinical course in most patients with carcinomas or sarcomas. Sometimes serological or molecular markers are used as prediction markers, but there has been no reliable marker for chondroid tumor diagnosis. Clinical and radiological, but not histological features, are still used in the diagnosis and staging of chondroid tumors. During a histopathological diagnosis, it has been difficult to distinguish between benign enchondroma and low-grade chondrosarcoma. To allow for more accurate treatments, new histological biomarkers for the differential diagnosis are needed. METHODS: Twenty-eight cases of enchondromas and thirty-three cases of low-grade chondrosarcoma were selected. Thirteen cases of non-tumorous cartilage were used for the control group, who underwent artificial joint surgery for degenerative arthritis. Surgically removed tissue specimens were formalin-fixed paraffin-embedded and hematoxylin and eosin (H&E) and immunohistochemistry (IHC) stains were performed. RESULTS: Periostin was expressed in chondroid tumors but not in the normal cartilage. Periostin was observed via immunostaining in the cytoplasm but not in the extracellular matrix of enchondroma tissue, and was observed in the cytoplasm and extracellular matrix of low-grade chondrosarcoma. The sensitivity and specificity of these stains were 93.9% and 96.4%, respectively. CONCLUSIONS: Based on these results, we suggest that periostin could be used as a novel prognostic marker to distinguish between enchondroma and low-grade chondrosarcoma. |
format | Online Article Text |
id | pubmed-8798228 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-87982282022-02-02 Periostin is a novel histological biomarker for the diagnosis of chondroid tumor Kim, Dough Jeong, Ji Yun Han, Man-Hoon Chae, Jongmin Park, Ilhyung Yoon, Jongphil Kyung, Heesoo Kim, Ha-Jeong Jeong, Wonju Transl Cancer Res Original Article BACKGROUND: The chondroid tumor is generally classified into three types, enchondroma, low-grade chondrosarcoma, and high-grade chondrosarcoma. A histological evaluation of a biopsy sample is the best predictor of the clinical course in most patients with carcinomas or sarcomas. Sometimes serological or molecular markers are used as prediction markers, but there has been no reliable marker for chondroid tumor diagnosis. Clinical and radiological, but not histological features, are still used in the diagnosis and staging of chondroid tumors. During a histopathological diagnosis, it has been difficult to distinguish between benign enchondroma and low-grade chondrosarcoma. To allow for more accurate treatments, new histological biomarkers for the differential diagnosis are needed. METHODS: Twenty-eight cases of enchondromas and thirty-three cases of low-grade chondrosarcoma were selected. Thirteen cases of non-tumorous cartilage were used for the control group, who underwent artificial joint surgery for degenerative arthritis. Surgically removed tissue specimens were formalin-fixed paraffin-embedded and hematoxylin and eosin (H&E) and immunohistochemistry (IHC) stains were performed. RESULTS: Periostin was expressed in chondroid tumors but not in the normal cartilage. Periostin was observed via immunostaining in the cytoplasm but not in the extracellular matrix of enchondroma tissue, and was observed in the cytoplasm and extracellular matrix of low-grade chondrosarcoma. The sensitivity and specificity of these stains were 93.9% and 96.4%, respectively. CONCLUSIONS: Based on these results, we suggest that periostin could be used as a novel prognostic marker to distinguish between enchondroma and low-grade chondrosarcoma. AME Publishing Company 2021-01 /pmc/articles/PMC8798228/ /pubmed/35116273 http://dx.doi.org/10.21037/tcr-20-2499 Text en 2021 Translational Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/. |
spellingShingle | Original Article Kim, Dough Jeong, Ji Yun Han, Man-Hoon Chae, Jongmin Park, Ilhyung Yoon, Jongphil Kyung, Heesoo Kim, Ha-Jeong Jeong, Wonju Periostin is a novel histological biomarker for the diagnosis of chondroid tumor |
title | Periostin is a novel histological biomarker for the diagnosis of chondroid tumor |
title_full | Periostin is a novel histological biomarker for the diagnosis of chondroid tumor |
title_fullStr | Periostin is a novel histological biomarker for the diagnosis of chondroid tumor |
title_full_unstemmed | Periostin is a novel histological biomarker for the diagnosis of chondroid tumor |
title_short | Periostin is a novel histological biomarker for the diagnosis of chondroid tumor |
title_sort | periostin is a novel histological biomarker for the diagnosis of chondroid tumor |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798228/ https://www.ncbi.nlm.nih.gov/pubmed/35116273 http://dx.doi.org/10.21037/tcr-20-2499 |
work_keys_str_mv | AT kimdough periostinisanovelhistologicalbiomarkerforthediagnosisofchondroidtumor AT jeongjiyun periostinisanovelhistologicalbiomarkerforthediagnosisofchondroidtumor AT hanmanhoon periostinisanovelhistologicalbiomarkerforthediagnosisofchondroidtumor AT chaejongmin periostinisanovelhistologicalbiomarkerforthediagnosisofchondroidtumor AT parkilhyung periostinisanovelhistologicalbiomarkerforthediagnosisofchondroidtumor AT yoonjongphil periostinisanovelhistologicalbiomarkerforthediagnosisofchondroidtumor AT kyungheesoo periostinisanovelhistologicalbiomarkerforthediagnosisofchondroidtumor AT kimhajeong periostinisanovelhistologicalbiomarkerforthediagnosisofchondroidtumor AT jeongwonju periostinisanovelhistologicalbiomarkerforthediagnosisofchondroidtumor |